Updated Nov. 14, 2023 5:07 pm ETThe latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1155 ET – Canopy Growth has been blowing through far less cash after exiting its BioSteel business, but John Zamparo of CIBC says debt still weighs heavily on the cannabis company. In a report, the analyst says even by approaching positive Ebitda territory early next year, the improvement doesn’t address Canopy’s large and growing debt load. “Even if Canopy manages a 5% Ebitda margin, that still implies an annual free cash flow loss of more than $75 million because of interest charges,” he says. Instead, Zamparo thinks that only an equity issuance over the next few years can help solve the issue, “and recent examples of thi...